S
Sinae Kim
Researcher at Rutgers University
Publications - 51
Citations - 537
Sinae Kim is an academic researcher from Rutgers University. The author has contributed to research in topics: Radiation therapy & Prostate cancer. The author has an hindex of 11, co-authored 51 publications receiving 344 citations.
Papers
More filters
Journal ArticleDOI
Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC.
Nikhil Yegya-Raman,Kyle Wang,Sinae Kim,Meral Reyhan,Matthew P. Deek,Mutlay Sayan,Diana Li,Malini Patel,Jyoti Malhotra,Joseph Aisner,Lawrence B. Marks,Salma K. Jabbour +11 more
TL;DR: In this paper, the authors retrospectively reviewed the records of 140 patients with inoperable NSCLC treated with concurrent chemoradiation therapy (CRT) from 2007 to 2015.
Journal ArticleDOI
Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy.
Salma K. Jabbour,Sinae Kim,Syed A. Haider,Xiaoting Xu,Alson Wu,Sujani G. Surakanti,Joseph Aisner,John Langenfeld,Ning J. Yue,Bruce G. Haffty,Wei Zou +10 more
TL;DR: TV reduction as determined by CBCT during CRT as part of routine care predicts post-CRT survival, and knowledge may justify intensification of RT or application of additional therapies.
Journal ArticleDOI
Montelukast in hospitalized patients diagnosed with COVID-19.
Ahsan R. Khan,Christian Misdary,Nikhil Yegya-Raman,Sinae Kim,Navaneeth Narayanan,Sheraz Siddiqui,Padmini Salgame,Jared Radbel,Frank De Groote,Carl Michel,Janice M. Mehnert,Caleb Hernandez,Thomas J. Braciale,Jyoti Malhotra,Michael A. Gentile,Michael A. Gentile,Salma K. Jabbour +16 more
TL;DR: It is suggested that montelukast associates with a reduction in clinical deterioration for COVID-19 confirmed patients as measured on the CO VID-19 Ordinal Scale and future efforts should evaluate this potential therapy.
Journal ArticleDOI
Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer.
Matthew P. Deek,Brian Benenati,Sinae Kim,Ting Chen,Inaya Ahmed,Wei Zou,Joseph Aisner,Salma K. Jabbour +7 more
TL;DR: Hematologic toxicity is associated with greater RT doses to the TV during CRT for NSCLC and sparing of the TV using advanced radiation techniques may improve tolerance of CRT and result in improved tolerance of concurrent chemotherapy.
Journal ArticleDOI
Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer
Shang-Jui Wang,Shang-Jui Wang,Karishma Khullar,Sinae Kim,Nikhil Yegya-Raman,Nikhil Yegya-Raman,Jyoti Malhotra,Roman Groisberg,Samuel H Crayton,Ann W. Silk,John L. Nosher,Michael A. Gentile,Janice M. Mehnert,Janice M. Mehnert,Salma K. Jabbour +14 more
TL;DR: It is suggested that COXi use concurrently with ICI is significantly associated with longer TTP and improved ORR at 6 months in patients with metastatic melanoma and NSCLC compared withICI alone.